檢索結果 - Cinzia Finocchi

  • Showing 1 - 12 results of 12
Refine Results
  1. 1
    Cut‐Off Values Able to Identify Migraine Patients With Increased Pressure‐Pain Sensitivity Independent of the Migraine Cycle Through a Single Assessment: A Secondary Analysis of a Multicentre, Cross‐Sectional, Observational Study

    Cut‐Off Values Able to Identify Migraine Patients With Increased Pressure‐Pain Sensitivity Independent of the Migraine Cycle Through a Single Assessment: A Secondary Analysis of a... 由 Matteo Castaldo, Lars Arendt‐Nielsen, Marta Ponzano, Francesca Bovis, Paola Torelli, Cinzia Finocchi, Stefano Di Antonio

    出版 2025
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  2. 2
    Transcranial Doppler sonography for detecting stenosis or occlusion of intracranial arteries in people with acute ischaemic stroke

    Transcranial Doppler sonography for detecting stenosis or occlusion of intracranial arteries in people with acute ischaemic stroke 由 A. Mattioni, Silvia Cenciarelli, Paolo Eusebi, Miriam Brazzelli, Tatiana Mazzoli, Massimo Del Sette, Claudia Gandolfo, Marinella Marinoni, Cinzia Finocchi, Valentina Saia, Stefano Ricci

    出版 2020
    獲取全文
    Revisão
    加到收藏夾
    Saved in:
  3. 3
    Three-year treatment with anti-CGRP monoclonal antibodies modifies migraine course: the prospective, multicenter I-GRAINE study

    Three-year treatment with anti-CGRP monoclonal antibodies modifies migraine course: the prospective, multicenter I-GRAINE study 由 Piero Barbanti, Cinzia Aurilia, Paola Torelli, Gabriella Egeo, Florindo d’Onofrio, Cinzia Finocchi, Antonio Carnevale, Giovanna Viticchi, Marco Russo, Simone Quintana, Bianca Orlando, Giulia Fiorentini, Roberta Messina, Marco Bartolini, Francesca Pistoia, Massimo Filippi, Stefano Bonassi, Sabina Cevoli, Alice Mannocci

    出版 2025
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  4. 4
    Anti-Rituximab antibodies Occurrence and Clinical Outcomes in patients with Primary Membranous Nephropathy

    Anti-Rituximab antibodies Occurrence and Clinical Outcomes in patients with Primary Membranous Nephropathy 由 Marco Allinovi, Maxime Teisseyre, Matteo Accinno, Cinzia Finocchi, Vincent Esnault, Marion Crémoni, Tommaso Mazzierli, Daniela Lazzarini, Micaela Anna Casiraghi, Céline Fernandez, Kévin Zorzi, Vesna Brglez, Lorenzo Cosmi, Andrea Matucci, Leonardo Caroti, Giulia Antognoli, Calogero Lino Cirami, Alessandra Vultaggio, Barbara Seitz‐Polski

    出版 2025
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  5. 5
    Maintenance of response and predictive factors of 1‐year <scp>GalcanezumAb</scp> treatment in real‐life migraine patients in <scp>Italy</scp>: The multicenter prospective cohort <scp>GARLIT</scp> study

    Maintenance of response and predictive factors of 1‐year <scp>GalcanezumAb</scp> treatment in real‐life migraine patients in <scp>Italy</scp>: The multicenter prospective cohort <s... 由 Fabrizio Vernieri, Nicoletta Brunelli, Marilena Marcosano, Cinzia Aurilia, Gabriella Egeo, Carlo Lovati, Valentina Favoni, Armando Perrotta, Ilaria Maestrini, Renata Rao, Luigi d’Onofrio, Cinzia Finocchi, Marco Aguggia, Francesco Bono, Angelo Ranieri, Maria Albanese, Vittorio Di Piero, Sabina Cevoli, Claudia Altamura, Piero Barbanti

    出版 2022
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  6. 6
    Galcanezumab for the prevention of high frequency episodic and chronic migraine in real life in Italy: a multicenter prospective cohort study (the GARLIT study)

    Galcanezumab for the prevention of high frequency episodic and chronic migraine in real life in Italy: a multicenter prospective cohort study (the GARLIT study) 由 Fabrizio Vernieri, Claudia Altamura, Nicoletta Brunelli, Carmelina Maria Costa, Cinzia Aurilia, Gabriella Egeo, Luisa Fofi, Valentina Favoni, Giulia Pierangeli, Carlo Lovati, Marco Aguggia, Florindo d’Onofrio, Alberto Doretti, Paola Di Fiore, Cinzia Finocchi, Renata Rao, Francesco Bono, Angelo Ranieri, Maria Albanese, Sabina Cevoli, Piero Barbanti

    出版 2021
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  7. 7
    Predictors of response to anti-CGRP monoclonal antibodies: a 24-week, multicenter, prospective study on 864 migraine patients

    Predictors of response to anti-CGRP monoclonal antibodies: a 24-week, multicenter, prospective study on 864 migraine patients 由 Piero Barbanti, Gabriella Egeo, Cinzia Aurilia, Claudia Altamura, Florindo d’Onofrio, Cinzia Finocchi, Maria Albanese, Marco Aguggia, Renata Rao, Maurizio Zucco, Fabio Frediani, Massimo Filippi, Roberta Messina, Sabina Cevoli, Antonio Carnevale, Giulia Fiorentini, Stefano Messina, Francesco Bono, Paola Torelli, Stefania Proietti, Stefano Bonassi, Fabrizio Vernieri

    出版 2022
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  8. 8
    Ultra-late response (&gt; 24 weeks) to anti-CGRP monoclonal antibodies in migraine: a multicenter, prospective, observational study

    Ultra-late response (&gt; 24 weeks) to anti-CGRP monoclonal antibodies in migraine: a multicenter, prospective, observational study 由 Piero Barbanti, Cinzia Aurilia, Gabriella Egeo, Stefania Proietti, Florindo d’Onofrio, Paola Torelli, Marco Aguggia, Davide Bertuzzo, Cinzia Finocchi, Michele Trimboli, Sabina Cevoli, Giulia Fiorentini, Bianca Orlando, Maurizio Zucco, Laura Di Clemente, Ilaria Cetta, Bruno Colombo, Monica Laura Bandettini di Poggio, Valentina Favoni, Licia Grazzi, Antonio Salerno, Antonio Carnevale, Micaela Robotti, Fabio Frediani, Claudia Altamura, Massimo Filippi, Fabrizio Vernieri, Stefano Bonassi

    出版 2024
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  9. 9
    Late Response to Anti-CGRP Monoclonal Antibodies in Migraine

    Late Response to Anti-CGRP Monoclonal Antibodies in Migraine 由 Piero Barbanti, Cinzia Aurilia, Gabriella Egeo, Paola Torelli, Stefania Proietti, Sabina Cevoli, Stefano Bonassi, Giulia Fiorentini Psy, Roberta Messina, Bruno Colombo, Florindo d’Onofrio, Maria Albanese, Cinzia Finocchi, Antonio Salerno, B. Mercuri, Antonio Carnevale, Francesco Bono, Fabio Frediani, Licia Grazzi, Domenico D’Amico, Massimo Filippi, Claudia Altamura, Fabrizio Vernieri, Marco Aguggia, Davide Bertuzzo, Maurizio Zucco, Laura Di Clemente, Michele Trimboli, Valentina Favoni, Paola Di Fiore

    出版 2023
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  10. 10
    Assessing the Long-Term (48-Week) Effectiveness, Safety, and Tolerability of Fremanezumab in Migraine in Real Life: Insights from the Multicenter, Prospective, FRIEND3 Study

    Assessing the Long-Term (48-Week) Effectiveness, Safety, and Tolerability of Fremanezumab in Migraine in Real Life: Insights from the Multicenter, Prospective, FRIEND3 Study 由 Piero Barbanti, Gabriella Egeo, Stefania Proietti, Florindo d’Onofrio, Cinzia Aurilia, Cinzia Finocchi, Laura Di Clemente, Maurizio Zucco, Alberto Doretti, Stefano Messina, Massimo Autunno, Angelo Ranieri, Antonio Carnevale, Bruno Colombo, Massimo Filippi, Miriam Tasillo, Steno Rinalduzzi, Pietro Querzani, Giuliano Sette, Lorenzo Forino, Francesco Zoroddu, Micaela Robotti, Alessandro Valenza, Cecilia Camarda, L. Borrello, Marco Aguggia, Giovanna Viticchi, Carlo Tomino, Giulia Fiorentini, Bianca Orlando, Stefano Bonassi, Paola Torelli

    出版 2024
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  11. 11
    Conversion from chronic to episodic migraine in patients treated with galcanezumab in real life in Italy: the 12-month observational, longitudinal, cohort multicenter GARLIT experience

    Conversion from chronic to episodic migraine in patients treated with galcanezumab in real life in Italy: the 12-month observational, longitudinal, cohort multicenter GARLIT experi... 由 Claudia Altamura, Nicoletta Brunelli, Marilena Marcosano, Cinzia Aurilia, Gabriella Egeo, Carlo Lovati, Valentina Favoni, Armando Perrotta, Ilaria Maestrini, Francesca Schiano di Cola, Florindo d’Onofrio, Cinzia Finocchi, Davide Bertuzzo, Francesco Bono, Angelo Ranieri, Maria Albanese, Roberta Messina, Alberto Doretti, Vittorio Di Piero, Sabina Cevoli, Piero Barbanti, Fabrizio Vernieri, Carmelina Maria Costa, Luisa Fofi, Renata Rao, Luigi d’Onofrio, Daniele Spitalieri, Marco Aguggia, Fabio Bombardieri, Bruno Colombo, Massimo Filippi, Stefano Messina, Gianluca Demirtzidis

    出版 2022
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  12. 12
    Early and sustained efficacy of fremanezumab over 24-weeks in migraine patients with multiple preventive treatment failures: the multicenter, prospective, real-life FRIEND2 study

    Early and sustained efficacy of fremanezumab over 24-weeks in migraine patients with multiple preventive treatment failures: the multicenter, prospective, real-life FRIEND2 study 由 Piero Barbanti, Gabriella Egeo, Cinzia Aurilia, Paola Torelli, Cinzia Finocchi, Florindo d’Onofrio, Luigi d’Onofrio, Renata Rao, Stefano Messina, Laura Di Clemente, Angelo Ranieri, Massimo Autunno, Giuliano Sette, Bruno Colombo, Antonio Carnevale, Marco Aguggia, Miriam Tasillo, Francesco Zoroddu, Fabio Frediani, Massimo Filippi, Carlo Tomino, Stefania Proietti, Stefano Bonassi, Maria Albanese, Marco Bertolini, Davide Bertuzzo, Maria Bloise, Francesco Bono, L. Borrello, Cecilia Camarda, Giulia Fiorentini, Licia Grazzi, Domenica Le Pera, Roberta Messina, Pietro Querzani, Antonio Salerno, Silvia Strumia, Alessandro Valenza, Fabrizio Vernieri, Giovanna Viticchi

    出版 2023
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:

檢索工具: